Citation:Bruno P, Mariotta S, Ricci A, Duranti E, Scozzi D, Noto A, et al 2011

From Cancer Guidelines Wiki

Citation


Bruno P, Mariotta S, Ricci A, Duranti E, Scozzi D, Noto A, et al. Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient. Anticancer Res 2011 Dec;31(12):4207-10 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22199282.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Bruno P, Mariotta S, Ricci A, Duranti E, Scozzi D, Noto A, et al 2011What specimen types are suitable for mutation testing in NSCLC patients?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What specimen types are suitable for mutation testing in NSCLC patients?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Bruno_P,_Mariotta_S,_Ricci_A,_Duranti_E,_Scozzi_D,_Noto_A,_et_al_2011&oldid=112225"